Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlling contagious bacterial conjunctivitis.

Steven J Lichtenstein1, Mark Dorfman, Robert Kennedy

  • 1University of Illinois at Peoria, University of Illinois at Chicago, Chicago, Illinois, USA.

Journal of Pediatric Ophthalmology and Strabismus
|February 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two Novel Cloud-Masking Algorithms Tested in a Tropical Forest Setting Using High-Resolution NICFI-Planet Basemaps.

Sensors (Basel, Switzerland)·2025
Same author

Correlation between mobile and 12-lead ECG among patients loading with intravenous sotalol: A PEAKS substudy.

Heart rhythm O2·2025
Same author

Sotalol Dosing and Outcomes Among Patients Undergoing Intravenous Loading for Atrial Arrhythmias-A PEAKS Registry Substudy.

Journal of cardiovascular electrophysiology·2025
Same author

3D Scanning of Surgical Specimens to Improve Communication Between Surgeon and Pathologist: A Head and Neck Pilot Study.

Cancers·2025
Same author

Population Pharmacokinetics and Pharmacodynamics of Sotalol Following Expedited Intravenous Loading in Patients With Atrial Arrhythmias.

CPT: pharmacometrics & systems pharmacology·2025
Same author

Expedited loading with intravenous sotalol is safe and feasible-primary results of the Prospective Evaluation Analysis and Kinetics of IV Sotalol (PEAKS) Registry.

Heart rhythm·2024
Same journal

TeleROP-NI: Modernizing Retinopathy of Prematurity Screening in Northern Ireland to Enhance Decision-making and Ensure Sustainability.

Journal of pediatric ophthalmology and strabismus·2026
Same journal

Ocular Microstructural Alterations in Children With Spina Bifida: An Optical Coherence Tomography Study.

Journal of pediatric ophthalmology and strabismus·2026
Same journal

Systemic Inflammatory Markers and Their Relationship With Optic Nerve Head Alterations in Pediatric Idiopathic Intracranial Hypertension.

Journal of pediatric ophthalmology and strabismus·2026
Same journal

Evaluating Large Language Models to Improve Spanish Patient Education on Childhood Glaucoma.

Journal of pediatric ophthalmology and strabismus·2026
Same journal

Comparative Evaluation of Unilateral Recession-Plication Versus Bilateral Three-Muscle Surgery for Large-Angle Exotropia.

Journal of pediatric ophthalmology and strabismus·2026
Same journal

Long-term Visual Sequelae of Shaken Baby Syndrome: A Retrospective Study of 52 Cases.

Journal of pediatric ophthalmology and strabismus·2026
See all related articles

Moxifloxacin demonstrated faster killing of Streptococcus pneumoniae than other antibiotics in vitro. This finding supports its use in treating bacterial conjunctivitis and limiting antibiotic resistance.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Recent outbreaks of Streptococcus pneumoniae conjunctivitis highlight the need for effective treatments.
  • Antimicrobial agents are crucial for reducing symptoms and transmission of bacterial conjunctivitis.

Purpose of the Study:

  • To compare the efficacy of various ophthalmic antibiotic solutions in killing Streptococcus pneumoniae.
  • To determine the time required for different antibiotics to eradicate S. pneumoniae.

Main Methods:

  • Streptococcus pneumoniae isolates were exposed to moxifloxacin, tobramycin, gentamicin, and polymyxin B-trimethoprim.
  • Antibiotic solutions were tested at dilutions of 1:100 and 1:1000.
  • Viable cell counts were determined at multiple time points post-exposure (15-180 minutes).

Related Experiment Videos

Main Results:

  • Moxifloxacin exhibited faster and more extensive killing of S. pneumoniae compared to other tested antibiotics.
  • This effect was observed at concentrations relevant to tear film levels post-instillation.

Conclusions:

  • Moxifloxacin shows superior in vitro activity against S. pneumoniae.
  • Its use may help minimize conjunctivitis symptoms and limit disease spread.
  • Prescribing newer fluoroquinolones like moxifloxacin aligns with strategies to combat antibiotic resistance.